Addmore Biopharm’s fully integrated drug discovery services increase the speed and efficiency of progressing from target validation, hit identification & validation, hit-to-lead, to lead optimization.

• Assay development: developing both biochemical and cell-based assays.
• High throughput screening: compound screening using our own 500,000 small molecule library.
• High content screening: phenotypic screening and analyzing at single cell level.
• Virtual screening: in silico screening using computer-aided drug design.
• Fragment-based lead generation to begin your structure-based discovery process.
• Structural biology: revealing structure-activity relationships by X-ray crystallography and NMR.
• Medicinal chemistry: designing and synthesizing new analogues.
• ADME/PK: performing comprehensive in vitro ADME/potency and in vivo ADME/PK assays.